Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe pump or ...

The FDA has doled out its most serious classification to a recall of some Cardinal Health medical supplies. In this case, the recall doesn’t describe a product removal, but merely a correction to the ...

The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...

Cardinal Health is removing a list of its own brand of Monoject sterile syringes from the U.S. market, the company said Friday, expanding on previous actions to address compatibility problems with ...

Only days after MD+DI reported Cardinal Health was embroiled in a Class I recall of its Cardinal branded Monoject syringes, FDA has moved to clarify its advice for clinicians specific to the recall.

Nov 20 (Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's (CAH.N), opens new tab Monoject syringes with ...

The FDA has identified this as a Class I recall, the most serious type of recall. There have been 13 reported injuries. There have been no reports of death. Get the Strategy to Trade Pre-Fed Setups ...

(RTTNews) - Cardinal Health Inc. has initiated a recall of around 267 million Monoject Flush Prefilled Saline Syringes (0.9% Sodium Chloride), the U.S. Food and Drug Administration announced. The ...